FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312205642> ?p ?o ?g. }

• W4312205642 endingPage "60" @default.
• W4312205642 startingPage "60" @default.
• W4312205642 abstract "This study aimed to investigate the pro-apoptotic effects of NSAID (Previcox®) in vitro and in vivo. Two CMT cell lines, one from the primary tumor and one from bone metastasis, were treated with firocoxib and MTT assay was performed to determine the half-maximal inhibitory concentration (IC50) value. The firocoxib IC50 for the cell lines UNESP-CM5 and UNESP-MM1 were 25.21 µM and 27.41 µM, respectively. The cell lines were then treated with the respective firocoxib IC50 concentrations and annexin V/propidium iodide (PI) assay was performed, to detect the induction of apoptosis in both cells (Annexin+/PI+). We conducted an in vivo study involving female dogs affected by CMT and divided them into control and treatment groups. For both groups, a biopsy was performed on day 0 (D0) and a mastectomy was performed on day 14 (D14). In the treatment group, after biopsy on D0, the patients received Previcox® 5 mg/kg PO once a day until mastectomy was performed on D14. COX-2/caspase-3 double immunostaining was performed on samples from D0 and D14, revealing no difference in the control group. In contrast, in the treatment group Previcox® increased the number of COX-2 positive apoptotic cells. Therefore, firocoxib can induce apoptosis in CMT cells in vitro and in vivo, and Previcox® can be a potential neoadjuvant treatment for patients with mammary cancer." @default.
• W4312205642 created "2023-01-04" @default.
• W4312205642 creator A5004354243 @default.
• W4312205642 creator A5009909863 @default.
• W4312205642 creator A5012390266 @default.
• W4312205642 creator A5012494350 @default.
• W4312205642 creator A5039377047 @default.
• W4312205642 creator A5039641455 @default.
• W4312205642 creator A5060696695 @default.
• W4312205642 creator A5062481180 @default.
• W4312205642 creator A5079689787 @default.
• W4312205642 date "2022-12-23" @default.
• W4312205642 modified "2023-10-17" @default.
• W4312205642 title "Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors" @default.
• W4312205642 cites W1966291916 @default.
• W4312205642 cites W1972104618 @default.
• W4312205642 cites W1998394615 @default.
• W4312205642 cites W2025534438 @default.
• W4312205642 cites W2044702943 @default.
• W4312205642 cites W2060377411 @default.
• W4312205642 cites W2061252160 @default.
• W4312205642 cites W2096283457 @default.
• W4312205642 cites W2119032282 @default.
• W4312205642 cites W2123107307 @default.
• W4312205642 cites W2150066887 @default.
• W4312205642 cites W2157805023 @default.
• W4312205642 cites W2163642722 @default.
• W4312205642 cites W2219172500 @default.
• W4312205642 cites W2315287261 @default.
• W4312205642 cites W2347059510 @default.
• W4312205642 cites W2548469661 @default.
• W4312205642 cites W2549784549 @default.
• W4312205642 cites W2560367415 @default.
• W4312205642 cites W2570987484 @default.
• W4312205642 cites W2765583492 @default.
• W4312205642 cites W2767596067 @default.
• W4312205642 cites W2799501577 @default.
• W4312205642 cites W2889646458 @default.
• W4312205642 cites W2896462778 @default.
• W4312205642 cites W2902050927 @default.
• W4312205642 cites W2904270500 @default.
• W4312205642 cites W2910749460 @default.
• W4312205642 cites W2954762607 @default.
• W4312205642 cites W2968063051 @default.
• W4312205642 cites W2994787101 @default.
• W4312205642 cites W2995873011 @default.
• W4312205642 cites W3110311041 @default.
• W4312205642 cites W3119005160 @default.
• W4312205642 cites W3133696967 @default.
• W4312205642 cites W3134201224 @default.
• W4312205642 cites W3169958602 @default.
• W4312205642 doi "https://doi.org/10.3390/ani13010060" @default.
• W4312205642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36611669" @default.
• W4312205642 hasPublicationYear "2022" @default.
• W4312205642 type Work @default.
• W4312205642 citedByCount "0" @default.
• W4312205642 crossrefType "journal-article" @default.
• W4312205642 hasAuthorship W4312205642A5004354243 @default.
• W4312205642 hasAuthorship W4312205642A5009909863 @default.
• W4312205642 hasAuthorship W4312205642A5012390266 @default.
• W4312205642 hasAuthorship W4312205642A5012494350 @default.
• W4312205642 hasAuthorship W4312205642A5039377047 @default.
• W4312205642 hasAuthorship W4312205642A5039641455 @default.
• W4312205642 hasAuthorship W4312205642A5060696695 @default.
• W4312205642 hasAuthorship W4312205642A5062481180 @default.
• W4312205642 hasAuthorship W4312205642A5079689787 @default.
• W4312205642 hasBestOaLocation W43122056421 @default.
• W4312205642 hasConcept C121608353 @default.
• W4312205642 hasConcept C126322002 @default.
• W4312205642 hasConcept C142724271 @default.
• W4312205642 hasConcept C150903083 @default.
• W4312205642 hasConcept C16685009 @default.
• W4312205642 hasConcept C185592680 @default.
• W4312205642 hasConcept C190283241 @default.
• W4312205642 hasConcept C204232928 @default.
• W4312205642 hasConcept C207001950 @default.
• W4312205642 hasConcept C26291073 @default.
• W4312205642 hasConcept C2775934118 @default.
• W4312205642 hasConcept C2775934546 @default.
• W4312205642 hasConcept C2780783641 @default.
• W4312205642 hasConcept C31573885 @default.
• W4312205642 hasConcept C4224716 @default.
• W4312205642 hasConcept C530470458 @default.
• W4312205642 hasConcept C55493867 @default.
• W4312205642 hasConcept C71924100 @default.
• W4312205642 hasConcept C74864618 @default.
• W4312205642 hasConcept C86803240 @default.
• W4312205642 hasConcept C88634738 @default.
• W4312205642 hasConceptScore W4312205642C121608353 @default.
• W4312205642 hasConceptScore W4312205642C126322002 @default.
• W4312205642 hasConceptScore W4312205642C142724271 @default.
• W4312205642 hasConceptScore W4312205642C150903083 @default.
• W4312205642 hasConceptScore W4312205642C16685009 @default.
• W4312205642 hasConceptScore W4312205642C185592680 @default.
• W4312205642 hasConceptScore W4312205642C190283241 @default.
• W4312205642 hasConceptScore W4312205642C204232928 @default.
• W4312205642 hasConceptScore W4312205642C207001950 @default.
• W4312205642 hasConceptScore W4312205642C26291073 @default.

• next